Sunandana Chandra, MD, MS, assistant professor of medicine, Division of Hematology and Oncology, Northwestern University Feinberg School of Medicine, discusses the incidence of targetable mutations in melanoma.
Archive | Video Reports
Dr. Chandra on the Incidence of Targetable Mutations in Melanoma
Posted in Melanoma News, Health Professionals, Video Reports
Dr. Shapiro on the Utility of Complete Lymph Node Dissection in Melanoma
David R. Gandara, MD, director, Thoracic Oncology Program, professor, senior advisor to director, University of California Davis Comprehensive Cancer Center, and a 2017 Giant of Cancer Care® in Lung Cancer, discusses measuring tumor mutational burden (TMB) in patients with non–small cell lung cancer (NSCLC) who received prior immunotherapy.
Posted in Melanoma News, Health Professionals, Video Reports
Dr. Chandra on Unanswered Questions With Targeted Therapy in Melanoma
Sunandana Chandra, MD, MS, assistant professor of medicine, Division of Hematology and Oncology, Northwestern University Feinberg School of Medicine, discusses unanswered questions regarding the utility of targeted therapy in melanoma.
Posted in Melanoma News, Health Professionals, Video Reports
Dr. Glitza Olivia on the Prognosis of Melanoma Brain Metastases
Isabella C. Glitza Oliva, MD, PhD, MS, an assistant professor within the Department of Melanoma Medical Oncology, Division of Cancer Medicine at The University of Texas MD Anderson Cancer Center, discusses the prognosis of patients with melanoma brain and/or central nervous system (CNS) metastases.
Posted in Melanoma News, Health Professionals, Video Reports
